Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Cytovia researchers identify new caspase activators

Aug. 5, 2004

OSI completes Tarceva NDA filing in NSCLC

Aug. 4, 2004

Structural GenomiX acquires Troxatyl rights

Aug. 4, 2004

Synthetic indole compound effective against multidrug resistant tumors in vivo

Aug. 4, 2004

New tubulin polymerization inhibitors covered by Cytopia patent

Aug. 4, 2004

New cinnoline-based antitumor agents in early development at Nippon Kayaku

Aug. 4, 2004

Louisiana State University and Bionomics enter cancer gene therapy agreement

Aug. 3, 2004

Gemzar combination therapy receives European approvals for ovarian cancer

Aug. 2, 2004

Novel HDAC inhibitors in early development at Roche

Aug. 2, 2004

Antitumor colchicine derivatives prepared at Aventis

Aug. 2, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...